Orili 150 Tablet

Orili 150 Tablet সম্পর্কে

Orili 150 হলো Elagolix-এর একটি ব্র্যান্ড, শক্তি ১৫০ mg, ট্যাবলেট আকারে। Orili 150 প্রস্তুত করেছে Square Pharmaceuticals PLC। Orili 150-এর সাথে Elagolix-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।

Elagolix-এর ৮টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Elagox 150 mg Tablet-এর, প্রতি ইউনিট ৳ ১৭০.০০।

Orili 150 Tablet কী?

Orili 150 is an oral tablet containing 150 mg of elagolix. Elagolix belongs to the gonadotropin-releasing hormone (GnRH) antagonist class of medicines. Endometriosis happens when tissue similar to the lining of the uterus grows outside it, which can cause pain during periods, pelvic pain between periods and pain during sex. These growths depend on the hormone estrogen, and elagolix works against the GnRH receptor to reduce that hormone-driven growth. Orili 150 is used for the management of moderate to severe pain associated with endometriosis. Only a registered doctor can decide whether it is suitable for a particular woman.

Orili 150-এর ব্যবহার

Orili 150 is used for the management of moderate to severe pain associated with endometriosis in women. Endometriosis is a condition in which tissue similar to the uterine lining grows outside the uterus, often on the ovaries, fallopian tubes or areas around the uterus. This can lead to pain during periods, pelvic pain between periods and pain during sexual intercourse. The medicine targets the GnRH receptor, which is involved in the estrogen-dependent growth of these lesions. It is not a treatment for other types of pain.

Orili 150 কীভাবে ব্যবহার করবেন

Orili 150 is taken by mouth. The doctor decides the dose, the number of times a day it is taken and how long the course lasts; those details are not fixed here. The tablet is usually taken at about the same time each day, with or without food. Pregnancy should be excluded before starting, or treatment started within the first days of a menstrual period. Do not change the schedule on your own. Ask your doctor or pharmacist if you are unsure about how to take it.

Orili 150-এর পার্শ্বপ্রতিক্রিয়া

Common side effects reported with elagolix include hot flushes and night sweats, headache, nausea, insomnia, missed periods (amenorrhea), anxiety, joint pain, and depression-related reactions or mood changes. Some people may notice other effects. Because mood changes and depression-related reactions can occur, tell your doctor if you feel low, anxious or notice any change in mood. Seek medical attention for thoughts of self-harm. Report any side effect that worries you to your doctor or pharmacist rather than stopping the medicine yourself.

সতর্কতা ও নিরাপত্তা

Orili 150 is not for use during pregnancy, and pregnancy should be ruled out before starting; if pregnancy occurs during treatment, the medicine should be stopped. It is also not for women with known osteoporosis or severe liver impairment, or those taking certain strong OATP 1B1 inhibitors such as cyclosporine and gemfibrozil. Elagolix can lower bone mineral density, may change menstrual bleeding so that pregnancy is harder to recognise, and can cause mood changes or suicidal thoughts; seek medical help for these. Tell your doctor about liver problems, bone problems, depression or anxiety, and all other medicines, including hormonal contraceptives, before starting.

সাধারণ প্রশ্ন

What is Orili 150 used for, and what kind of medicine is it?

Orili 150 is used for the management of moderate to severe pain associated with endometriosis in women. It is a gonadotropin-releasing hormone (GnRH) antagonist, given as a 150 mg tablet, and it acts on the GnRH receptor involved in the estrogen-dependent growth of endometriosis lesions.

How should Orili 150 be taken?

It is swallowed as a tablet, usually at about the same time each day, with or without food. The doctor decides the dose, how often it is taken and how long the course lasts. Do not change the schedule yourself; ask your doctor or pharmacist if anything is unclear.

What does the generic name elagolix mean?

Elagolix is the generic name of the active ingredient in Orili 150. It is a nonpeptide, small-molecule gonadotropin-releasing hormone (GnRH) receptor antagonist taken by mouth. The generic name identifies the medicine itself, while Orili 150 is the brand name under which Square Pharmaceuticals PLC supplies it.

Is Orili 150 safe during pregnancy?

It is not for use in pregnancy, and pregnancy should be excluded before starting treatment. If pregnancy happens while taking it, the medicine should be stopped and the doctor informed. Because it can change menstrual bleeding, pregnancy may be harder to notice, so testing is advised if pregnancy is suspected.

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Elagolix is indicated for the management of moderate to severe pain associated with endometriosis.

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Endometriosis develops when tissue that is similar to the kind that is normally located in the uterus starts to grow outside of the uterus. Such growth leads to various symptoms like pain during periods, pelvic pain between periods, and pain during sexual intercourse. The growths themselves are referred to as lesions and frequently develop on the ovaries, fallopian tubes, and other areas around the uterus, including the bowel or bladder. The growth of these lesions is dependent upon the estrogen hormone.

Elagolix is an orally-administered, nonpeptide small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist that inhibits endogenous GnRH signaling by binding competitively to GnRH receptors in the pituitary gland Label. Administration of elagolix results in dose-dependent suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to decreased blood concentrations of the ovarian sex hormones, estradiol and progesterone.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Exclude pregnancy before starting Elagolix or start Elagolix within 7 days from the onset of menses. Take Elagolix at approximately the same time each day, with or without food.

Initiate treatment with Elagolix 150 mg once daily-
  • Maximum Treatment Duration: 24 months
  • Coexisting Condition: None
Consider initiating treatment with Elagolix 200 mg twice daily-
  • Maximum Treatment Duration: 6 months
  • Coexisting Condition: Dyspareunia
Initiate treatment with Elagolix 150 mg once daily. Use of 200 mg twice daily is not recommended-
  • Maximum Treatment Duration: 6 months
  • Coexisting Condition: Moderate hepatic impairment (Child-Pugh Class B)

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

May potentiate P-gp substrates (eg. Digoxin), CYP2C19 substrates (eg. Dose limit of Omeprazole is upto 40mg daily). May antagonize CYP3A substrates. Antagonizes oral Midazolam, Rosuvastatin; consider increasing their doses. Maybe antagonized by CYP3A inducers. Reduces efcacy with estrogen-containing contraceptives.

প্রতিনির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Elagolix is contraindicated in women:
  • Who are pregnant
  • Exposure to ORILISSA early in pregnancy may increase the risk of early pregnancy loss.
  • With known osteoporosis because of the risk of further bone loss
  • With severe hepatic impairment because of the risk of bone loss
  • With concomitant use of strong organic anion transporting polypeptide (OATP) 1B1 inhibitors (e.g., cyclosporine and gemfibrozil)

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Most common adverse reactions (>5%) in clinical trials included hot flushes and night sweats, headache, nausea, insomnia, amenorrhea, anxiety, arthralgia, depression-related adverse reactions and mood changes.

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Exposure to Elagolix early in pregnancy may increase the risk of early pregnancy loss. Use of Elagolix is contraindicated in pregnant women. Discontinue Elagolix if pregnancy occurs during treatment. The limited human data with the use of Elagolix in pregnant women are insufficient to determine whether there is a risk for major birth defects or miscarriage. Although two cases of congenital malformations were reported in clinical trials with Elagolix, no pattern was identified and miscarriages were reported at a similar incidence across treatment groups. There is no information on the presence of elagolix or its metabolites in human milk, the effects on the breastfed child, or the effects on milk production.

There are no adequate animal data on the excretion of Elagolix in milk. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Elagolix and any potential adverse effects on the breastfed child from Elagolix.

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

  • Bone Loss: Dose- and duration-dependent decreases in bone mineral density (BMD) that may not be completely reversible. Assess BMD in women with additional risk factors for bone loss
  • Reduced Ability to Recognize Pregnancy: Elagolix may alter menstrual bleeding, which may reduce the ability to recognize pregnancy. Perform testing if pregnancy is suspected. Discontinue if pregnancy is confirmed
  • Suicidal Ideation and Mood Disorders: Advise patients to seek medical attention for suicidal ideation, suicidal behavior, new onset or worsening depression, anxiety, or other mood changes
  • Hepatic Transaminase Elevations: Dose-dependent elevations in serum alanine aminotransferase (ALT). Counsel patients on signs and symptoms of liver injury
  • Potential for Reduced Efficacy with Estrogen-Containing Contraceptives: Use non-hormonal contraception during treatment and for one week after discontinuing Elagolix.

মাত্রাধিক্যতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

In case of overdose, patients should be monitored for any signs or symptoms of adverse reactions and initiate appropriate symptomatic treatment, as needed.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

বিকল্প ব্র্যান্ড: Elagolix

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

Elagox Tablet

150 mg

Elagolix

Nuvista Pharma Ltd

৳ ১৬৬.৬ ৳ ১৭০.০০ ২% ছাড় প্রতি ইউনিট

Egolix 150 Tablet

150 mg

Elagolix

The ACME Laboratories Ltd.

দাম দেওয়া নেই

Egolix 200 Tablet

200 mg

Elagolix

The ACME Laboratories Ltd.

দাম দেওয়া নেই

Elagox 200 Tablet

200 mg

Elagolix

Nuvista Pharma Ltd

দাম দেওয়া নেই

Golixen 150 Tablet

150 mg

Elagolix

Advanced Chemical Industries PLC

দাম দেওয়া নেই

Orili 200 Tablet

200 mg

Elagolix

Square Pharmaceuticals PLC.

দাম দেওয়া নেই

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।